Genentech sues Biogen for debt over blockbuster MS drug

Published Date: 08 Mar 2023

Roche's Genentech Inc sued Biogen MA Inc in federal court in San Francisco, alleging that Biogen owed additional patent royalties from worldwide sales of its blockbuster multiple sclerosis and Crohn's disease drug, Tysabri.

Read Full News

Latest News

Immunotherapy Plus TACE Improves PFS in Unresectable HCC

The study adds to growing evidence that immunotherapy and chemoembolization prolong progression-free survival.

Flesh-eating Screwworm Confirmed in Texas Calf as Parasite Crosses Border From Mexico

New World screwworm, a parasitic fly that eats warm-blooded animals alive, has been found in a calf in Texas, the U.S. Department of Agriculture said on Wednesday evening,...

Iza-Bren Beats Chemo in Second-Line Esophageal Cancer

In a phase 3 trial, izalontamab brengitecan shows superiority to chemotherapy in previously treated esophageal squamous cell carcinoma, but questions remain about generalizability outside China.

Antibiotic Effects on the Gut Detected Up to 8 Years Later

Changes in gut microbiome diversity are observed with certain antibiotic drugs years later, even after just one course of therapy.

Natural Supplements Linked to Cases of Severe Liver Injury

Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.

Remote Monitoring in Cirrhosis Could Reduce Admissions

A digital monitoring system for advanced cirrhosis may help detect deterioration earlier and reduce hospital admissions.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Todays Updates

Smartphone App Detects Eye Cancers From Photos

A smartphone app that analyzes images of the eye may enable early screening for cancers of the eye surface, flag lesions at high risk for specialist review, and expand access beyond clinics.

Latest News

The study adds to growing evidence that immunotherapy and chemoembolization prolong progression-free survival.

New World screwworm, a parasitic fly that eats warm-blooded animals alive, has been found in a calf in Texas, the U.S. Department of Agriculture said on Wednesday evening,...

In a phase 3 trial, izalontamab brengitecan shows superiority to chemotherapy in previously treated esophageal squamous cell carcinoma, but questions remain about generalizability outside China.

Changes in gut microbiome diversity are observed with certain antibiotic drugs years later, even after just one course of therapy.

Experts warn that concentrated herbal and dietary supplements are increasingly linked to severe liver injury, while regulation remains limited.

A digital monitoring system for advanced cirrhosis may help detect deterioration earlier and reduce hospital admissions.

News All Time

Silent Reflux: Clinical Conundrum Solved via Proper Testing

A chronic cough without heartburn are the tell-tale signs of the condition; surgery is typically not the answer.

Zenocutuzumab OK’d for NRG1 Fusion+ Cholangiocarcinoma

The bispecific antibody has previously granted accelerated approval for advanced, unresectable, or metastatic non-small cell lung cancer and pancreatic adenocarcinoma harboring the gene fusions.

Sigmoidoscopy Cuts Colorectal Cancer Risk in Men

Researchers randomly assign more than 100,000 adults without CRC to receive once-only sigmoidoscopy screening or no screening between 1999 and 2001. Here’s what they find.

False Positive mt-sDNA Tests Could Flag Other Cancers

False-positive multi-target stool tests are linked to higher rates of noncolorectal aerodigestive cancers, suggesting further workup may be indicated in these patients.

HER2 Testing in Practice: Case-Based Insights to Improve Interpretation, Reporting, and Multidisciplinary Team Collaboration

HER2 Testing in Practice: Case-Based Insights to Improve Interpretation, Reporting, and Multidisciplinary Team Collaboration

Meeting the Challenge of Accurate and Timely Diagnosis of GEP-NETs

Meeting the Challenge of Accurate and Timely Diagnosis of GEP-NETs

Unlocking MMR and MSI: Paving the Path to Personalized Treatment in Early-Stage CRC

Unlocking MMR and MSI: Paving the Path to Personalized Treatment in Early-Stage CRC

Navigating Personalized Management of Advanced Upper GI Adenocarcinomas

Navigating Personalized Management of Advanced Upper GI Adenocarcinomas

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Precision Pathways: Matching Test Results to Therapy in Advanced G/GEJ Adenocarcinoma

Clinical Pearls to Advance Multidisciplinary Team-Based Care for Patients With GEP-NETs

Clinical Pearls to Advance Multidisciplinary Team-Based Care for Patients With GEP-NETs

Navigating the Future of Upper GI Cancer Treatment: Mechanisms, Personalization, and Expert Insights

Navigating the Future of Upper GI Cancer Treatment: Mechanisms, Personalization, and Expert Insights

Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care

Checkpoint, Claudin, and Beyond: Optimizing Biomarker-Driven Decisions in Advanced/Metastatic G/GEJ Cancer Care

EASL: European Association for the Study of the Liver

CCC: Crohn's & Colitis Congress

AASLD: American Association for the Study of Liver Diseases

ACG: American College of Gastroenterology

Recommended News For You

Shorter but More Intense RT: A Better Option for HNSCC?

Can Fasting Around Chemo Improve Ovarian Cancer Outcomes?

Durvalumab Plus BCG Earns FDA Nod for Bladder Cancer

More Positive Survival Data in Lung Cancer With Perioperative Therapy

The pancreatic ductal adenocarcinoma mRNA vaccine holds promise for preventing relapse.

Men With Prostate Cancer Experience Less Hot Flashes When Using an Affordable Drug.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

Recommended Articles For You

Cardio-Oncology in Survivors: Safeguarding Hearts Through Multidisciplinary Care 

Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era 

Voices That Heal: Redefining Cancer Care Through Patient Insights and Partnership 

Phosphate Vs. Phosphorus: What Is The Difference? 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

High numbers of rural patients cross state lines for cancer care

2.

Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.

3.

Cancer and HIV Vaccines Enter the Therapeutic Era

4.

Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.

5.

Sports for girls are frequently abandoned due to uniform issues.

1.

Bridging Disciplines: Medical Oncology vs Surgical Oncology in the Era of Multidisciplinary Cancer Care

2.

Transforming Cancer Care: Metrics, Informatics, Equity, and Real-World Evidence

3.

The Truth About Marijuana and Its Effect on Mental Health 

4.

A Comprehensive Guide To Understanding Plasma Osmolality

5.

Precision Oncology: How Personalized Medicine is Transforming Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Lung Cancer Congress®

5.

Genito-Urinary Oncology Summit 2026

1.

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part I

2.

Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary

3.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

4.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation

5.

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot